Stock Events

Stock Events

Caredx 

€43.00
82
+€0.20+0.47% Monday 19:56

Statistics

Day High
43.4
Day Low
41.6
52W High
43.4
52W Low
9.82
Volume
10
Avg. Volume
-
Mkt Cap
2.22B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q1 2026
Q2 2026
Next
0.11
0.18
0.25
0.32
Expected EPS
0.2152275
Actual EPS
N/A

Financials

-5.74%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
329.43MRevenue
-18.91MNet Income

Analyst Ratings

40.22Average Price Target
The highest estimate is 45.53.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1K9.STU. It's not an investment recommendation.
NVIDIA
18
NVDA
Tesla
17
TSLA
Amazon
17
AMZN
AMD
17
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Natera
NTRA
Mkt Cap47.03B
Natera offers similar organ transplant care solutions, including non-invasive genetic testing, directly competing with CareDx's offerings.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions that are foundational to the development of molecular diagnostics in transplantation, similar to CareDx's services.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing in the broader market of molecular diagnostics alongside CareDx.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, competing with CareDx in the field of genomic testing.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics offers comprehensive genetic testing, competing with CareDx in the genomic analysis market, including applications in transplantation.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories provides a range of products and services for life science research and clinical diagnostics, overlapping with CareDx's market.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of solutions for genomic sequencing and analysis, competing with CareDx in the diagnostics and research market.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing services, including for organ health, indirectly competing with CareDx's transplant diagnostics.

About

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Show more...
CEO
John Walter Hanna Jr.
Employees
765
Country
United States
ISIN
US14167L1035
WKN
000A118WG

Listings

STU
DE
1K9.STU
MU
DE
1K9.MU
XNAS
US
CDNA
F
DE
1K9.F

0 Comments

Share your thoughts

FAQ

What is Caredx stock price today?▼
The current price of 1K9.STU is €43.00 EUR — it has increased by +0.47% in the past 24 hours. Watch Caredx stock price performance more closely on the chart.
What is Caredx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Caredx stocks are traded under the ticker 1K9.STU.
Is Caredx stock price growing?▼
1K9.STU stock has fallen by -1.38% compared to the previous week, the month change is a +20.79% rise, over the last year Caredx has showed a +272.46% increase.
What is Caredx market cap?▼
Today Caredx has the market capitalization of 2.22B
When is the next Caredx earnings date?▼
Caredx is going to release the next earnings report on November 10, 2026.
What were Caredx earnings last quarter?▼
1K9.STU earnings for the last quarter are 0.32 EUR per share, whereas the estimation was 0.2 EUR resulting in a +59.39% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Caredx revenue for the last year?▼
Caredx revenue for the last year amounts to 329.43M EUR.
What is Caredx net income for the last year?▼
1K9.STU net income for the last year is -18.91M EUR.
How many employees does Caredx have?▼
As of September 01, 2026, the company has 765 employees.
In which sector is Caredx located?▼
Caredx operates in the Health & Wellness sector.
When did Caredx complete a stock split?▼
Caredx has not had any recent stock splits.
Where is Caredx headquartered?▼
Caredx is headquartered in BRISBANE, United States.